Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Henry I. Miller, M.D.
More GEN Content From This Contributor
- Columns: Better Science Means Safer Food
- Columns: Labeling Cloned Food Is Unnecessary
- Columns: Follow-On Biologics Policy Needs Science
- Columns: Risk-Averse Behavior Entrenched at FDA
- Columns: Antisocial Bio-Activism
- Columns: Firms Need to Focus on Profits
- Columns: Designing Improved Humans
- Columns: No Member of Congress Left Behind
- Columns: Thwarting Domestic Terrorism
- Columns: Vilification of Bovine Growth Hormone Udderly Unwarranted
- Columns: Overreacting to Perceived Risks
- Columns: Science and Technology Are Essential to Economic Recovery
- Columns: Activism, Mendacity, and Pathological Science
- Columns: Pharma Innovation in Critical Condition
- Columns: Tempering Regulation with Common Sense
- Columns: Precautionary Regulation Is What's Rotten in Denmark
- Feature Articles: Unlocking the Genetic Secrets of Autism
- Columns: No Frost Fix Thanks to Feds
- Columns: Benighted EC Politicians Reject Food from Cloned Animals
- Columns: A Golden Opportunity Choked by Red Tape
- Columns: NIH Pharma Co. Is a Bad Idea
- Columns: FDA Thumps Industry, Patients Feel the Pain
- Columns: How Is the FDA Really Doing?
- Columns: Waste and Abuse in Federal Research Funding
- Columns: Technophobia = Poisoned Fruit
- Columns: Anti-Genetic Engineering Activism: Why the Bastards Never Quit
- Columns: Anti-GE Activism: Will It Ever End?
- Columns: Are Medical Articles True on Health, Disease?